DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie


Van Cutsem E, Lang I, D’haens G et al.
KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience.

J Clin Oncol 2008;
26 (abstr 2)

Download Bibliographical Data

Search in: